How new tobacco designs and added flavors influence who starts and prefers them
Impact of new tobacco product design and synthetic additives on use initiation and preference behavior
This project looks at whether new kinds of tobacco products and added flavors make people—especially young people—more likely to start using and prefer these products.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11166466 on NIH RePORTER |
What this research studies
You would learn what chemicals are inside oral nicotine pouches and recently marketed cigarettes and how quickly nicotine and flavors are released from them. Scientists will run lab chemical analyses and bioassays to measure release and irritation, and they will pair those data with behavioral tests measuring product preference and nicotine intake. The team will compare responses across age groups, focusing on adolescents and adults, to see if certain flavors or additives make initiation or continued use more likely. Results will help link product chemistry to real-world liking and use patterns.
Who could benefit from this research
Good fit: Ideal candidates include adolescents and adults who use or might try nicotine products—such as current smokers, recent quitters, and young people at risk of starting.
Not a fit: People who do not use nicotine, cannot legally use tobacco products, or are uninterested in nicotine-related research are unlikely to get direct benefit from participating.
Why it matters
Potential benefit: If successful, the findings could help regulators and public-health officials limit product features that attract new users and reduce youth nicotine initiation.
How similar studies have performed: Previous work shows flavors increase appeal and use risk, but the specific role of synthetic sweeteners in oral nicotine pouches and additives in 'non-menthol' cigarettes is less well studied.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Jordt, Sven-Eric — Duke University
- Study coordinator: Jordt, Sven-Eric
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.